INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $238,726 | -6.2% | 5,854 | -14.2% | 0.01% | -22.2% |
| Q1 2023 | $254,405 | -30.5% | 6,826 | +4.3% | 0.01% | -47.1% |
| Q3 2022 | $366,000 | +12.6% | 6,546 | +4.4% | 0.02% | +13.3% |
| Q2 2022 | $325,000 | +16.1% | 6,272 | +63.0% | 0.02% | +7.1% |
| Q1 2022 | $280,000 | -4.1% | 3,848 | +55.6% | 0.01% | -17.6% |
| Q4 2021 | $292,000 | -40.5% | 2,473 | -32.4% | 0.02% | -61.4% |
| Q3 2021 | $491,000 | – | 3,659 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |